An interventional study of Sham taVNS and taVNS 10 Hz in Healthy Volunteers, sponsored by Sinop University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-16.
Sponsored by Sinop University · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This randomized, participant-blinded, sham-controlled crossover study aims to investigate the acute effects of different frequency applications of transcutaneous auricular vagus nerve stimulation (taVNS) on autonomic physiological responses in healthy adults. Participants will receive sham (0 Hz), 10 Hz, 25 Hz, 50 Hz, and 100 Hz taVNS in separate sessions with washout periods between visits. Heart rate variability, blood pressure, pulse rate, respiratory rate, and subjective discomfort will be assessed before and after each intervention session.
The vagus nerve is a major regulator of the parasympathetic branch of the autonomic nervous system. Transcutaneous auricular vagus nerve stimulation (taVNS) is a non-invasive neuromodulation technique applied to auricular regions innervated by the auricular branch of the vagus nerve. Although taVNS has been reported to modulate autonomic function, the acute physiological effects of different stimulation frequencies remain insufficiently characterized.
This study is designed as a randomized, participant-blinded, sham-controlled crossover trial in healthy adults aged 18 to 40 years. Each participant will undergo five intervention conditions in randomized order: sham (0 Hz), 10 Hz, 25 Hz, 50 Hz, and 100 Hz taVNS. Sessions will be separated by 48 to 72 hours to minimize carryover effects. Each stimulation session will last 10 minutes.
Primary autonomic outcomes will be derived from heart rate variability parameters obtained using a Polar H10 chest strap and analyzed with Kubios HRV software. Secondary physiological outcomes will include systolic and diastolic blood pressure, pulse rate, respiratory rate, and subjective discomfort measured using a visual analog scale. The study aims to identify frequency-specific autonomic response profiles and to evaluate whether respiratory rate influences heart rate variability changes associated with taVNS.
Sinop University is the lead sponsor of 35 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants receive sham stimulation during one study session.
Device: Sham taVNS
Participants receive active transcutaneous auricular vagus nerve stimulation at 10 Hz during one study session.
Device: taVNS 10 Hz
Participants receive active transcutaneous auricular vagus nerve stimulation at 25 Hz during one study session.
Device: taVNS 25 Hz
Participants receive active transcutaneous auricular vagus nerve stimulation at 50 Hz during one study session.
Device: taVNS 50 Hz
Participants receive active transcutaneous auricular vagus nerve stimulation at 100 Hz during one study session.
Device: taVNS 100 Hz
Sham stimulation is delivered under conditions similar to active taVNS without meaningful vagal stimulation.
Active transcutaneous auricular vagus nerve stimulation applied for 10 minutes at 10 Hz.
Active transcutaneous auricular vagus nerve stimulation applied for 10 minutes at 25 Hz.
Active transcutaneous auricular vagus nerve stimulation applied for 10 minutes at 50 Hz.
Active transcutaneous auricular vagus nerve stimulation applied for 10 minutes at 100 Hz.
Change in Root Mean Square of Successive Differences (RMSSD)
Change in the root mean square of successive differences (RMSSD) from pre-intervention to post-intervention under each stimulation condition.
Time frame: Immediately before and immediately after each 10-minute intervention session
Change in High-Frequency Heart Rate Variability (HF-HRV)
Change in high-frequency heart rate variability (HF-HRV) from pre-intervention to post-intervention under each stimulation condition.
Time frame: Immediately before and immediately after each 10-minute intervention session
Change in Standard Deviation of Normal-to-Normal RR Intervals (SDNN)
Change in the standard deviation of normal-to-normal RR intervals (SDNN) from pre-intervention to post-intervention under each stimulation condition.
Time frame: Immediately before and immediately after each 10-minute intervention session
Change in Low-Frequency (LF) Power
Change in low-frequency (LF) power of heart rate variability from pre-intervention to post-intervention under each stimulation condition.
Time frame: Immediately before and immediately after each 10-minute intervention session
Change in LF/HF Ratio
Change in the ratio of low-frequency to high-frequency heart rate variability (LF/HF ratio) from pre-intervention to post-intervention under each stimulation condition.
Time frame: Immediately before and immediately after each 10-minute intervention session
Change in Systolic Blood Pressure
Change in systolic blood pressure from pre-intervention to post-intervention under each stimulation condition.
Time frame: Immediately before and immediately after each 10-minute intervention session
Change in Diastolic Blood Pressure
Change in diastolic blood pressure from pre-intervention to post-intervention under each stimulation condition.
Time frame: Immediately before and immediately after each 10-minute intervention session
Change in Pulse Rate
Change in pulse rate from pre-intervention to post-intervention under each stimulation condition.
Time frame: Immediately before and immediately after each 10-minute intervention session
Change in Respiratory Rate
Change in respiratory rate from pre-intervention to post-intervention under each stimulation condition.
Time frame: Immediately before and immediately after each 10-minute intervention session
Change in Subjective Discomfort Assessed by Visual Analog Scale (VAS)
Subjective discomfort will be assessed using a Visual Analog Scale (VAS) ranging from 0 to 10, where 0 indicates no discomfort and 10 indicates the worst possible discomfort. Higher scores indicate greater discomfort. Change in VAS score from pre-intervention to post-intervention will be evaluated under each stimulation condition.
Time frame: Immediately before and immediately after each 10-minute intervention session
Plan to share: No
Start is estimated for May 2026; primary completion for May 2026, 0 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sinop University